Groupe la Francaise’s TuHURA Biosciences HURA Stock Holding History

Groupe la Francaise’s Portfolio HURA Stock Details HURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-357	Closed	-$751	–	808
2025 Q3	$751	Buy	+357	New	+$940	﹤0.01%	744

Other funds holding HURA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AWM

Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return

SEM

Suncoast Equity Management Tampa, Florida $798M AUM 14.62% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Groupe la Francaise's HURA Position: Q4 2025 in Review

Groupe la Francaise sold out of TuHURA Biosciences (HURA) in Q4 2025, closing a stake of 357 shares — an estimated $751 sold.

Groupe la Francaise first reported a position in HURA in Q3 2025 and held it in 1 quarter. The position peaked at $751 in Q3 2025. 65 funds tracked by Wall St. Rank hold HURA as of Q4 2025.

Groupe la Francaise reported no remaining TuHURA Biosciences position as of Q4 2025 after selling out during the quarter.
Groupe la Francaise sold 357 TuHURA Biosciences shares in Q4 2025, an estimated $751.
Groupe la Francaise first reported a position in TuHURA Biosciences in Q3 2025 and held it in 1 quarter.
Groupe la Francaise's TuHURA Biosciences position peaked at $751 in Q3 2025.
65 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q4 2025.

Based on Groupe la Francaise's 13F filing for Q4 2025, filed 12 Feb 2026.